Skip to main content
75 search results for:

Uveitis 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 23-03-2022 | Axial spondyloarthritis | News | Article

    Acute anterior uveitis may point to axSpA risk in relatives of people with ankylosing spondylitis

    Researchers have identified factors that may signal increased axial spondyloarthritis risk among family members of patients with ankylosing spondylitis, including the presence of acute anterior uveitis.

  2. 04-06-2021 | EULAR 2021 | Conference coverage | Article

    Uveitis risk warning in JIA patients discontinuing DMARD therapy

    Patients with juvenile idiopathic arthritis are at high risk for uveitis in the first 24 months of discontinuing DMARD therapy, findings from the EULAR 2021 Virtual Congress indicate.

  3. 22-10-2019 | Juvenile idiopathic arthritis | News | Article

    Etanercept not linked to uveitis risk in real-world JIA study

    An analysis of two UK juvenile idiopathic arthritis registries suggests no significant difference in uveitis risk among patients treated with the TNF inhibitor etanercept relative to methotrexate.

  4. 11-11-2019 | Axial spondyloarthritis | ACR/ARP 2019 | Article

    Certolizumab pegol shows dual role for axSpA and acute anterior uveitis

    Certolizumab pegol significantly reduces the risk for acute anterior uveitis flare in patients with axial spondyloarthritis, show 48-week interim results from the C-VIEW trial.

  5. 06-06-2020 | EULAR 2020 | Conference coverage | Article
    News in brief

    Etanercept linked to elevated risk for anterior uveitis in patients with SpA

    Etanercept is associated with a higher risk for anterior uveitis than adalimumab among patients with spondyloarthritis, suggests a Swedish registry study.

  6. 22-10-2019 | Juvenile idiopathic arthritis | Highlight | Teaser
    medwireNews top story

    Etanercept not linked to uveitis risk in real-world JIA study

    An analysis of two UK juvenile idiopathic arthritis registries suggests no significant difference in uveitis risk among patients treated with the TNF inhibitor etanercept relative to methotrexate.

  7. 05-07-2019 | Behçet’s disease | News | Article

    Favorable results with TNF inhibitors in Behçet's disease-associated uveitis

    The tumor necrosis factor inhibitors adalimumab and infliximab both show good efficacy when used as first biologic agents in patients with refractory uveitis due to Behçet's disease, Spanish research shows.

  8. 17-06-2019 | Juvenile idiopathic arthritis | EULAR 2019 | Article

    Further investigation of tocilizumab for JIA-associated uveitis may be warranted

    Approximately half of the 21 patients with juvenile idiopathic arthritis-associated uveitis in the APTITUDE trial experienced an improvement in uveitis assessment with 12 weeks of tocilizumab treatment.

  9. 11-01-2019 | Juvenile idiopathic arthritis | News | Article
    News in brief

    Predictors of outcomes identified in JIA-associated uveitis

    Demographic factors, measures of disease activity, and the type of treatment used are associated with 2-year outcomes among patients with juvenile idiopathic arthritis-associated uveitis, according to findings from the ICON-JIA study.

  10. 13-11-2018 | TNF inhibitors | Highlight | Teaser
    medwireNews editor's pick

    Golimumab may reduce uveitis risk in patients with ankylosing spondylitis

    Findings from the real-world GO-EASY study suggest that treatment with the tumor necrosis factor inhibitor golimumab is associated with a significant reduction in the risk for acute anterior uveitis among patients with ankylosing spondylitis.

  11. 13-11-2018 | Ankylosing spondylitis | News | Article

    Golimumab may reduce uveitis risk in patients with ankylosing spondylitis

    Findings from the real-world GO-EASY study suggest that treatment with the tumor necrosis factor inhibitor golimumab is associated with a significant reduction in the risk for acute anterior uveitis among patients with ankylosing spondylitis.

  12. 11-05-2018 | Teaser

    Detecting and treating JIA-associated uveitis

    The recently published SHARE recommendations provide guidance on screening, diagnosis, and treatment for JIA-associated uveitis.  medwireNews  looks at the key features of the guidelines, and talks to specialists about the impact they will have.

  13. 11-05-2018 | Juvenile idiopathic arthritis | Feature | Article

    Managing JIA-associated uveitis: An ophthalmologist’s perspective

    medwireNews  talks to consultant ophthalmologist Carlos Pavesio about the SHARE initiative recommendations on treating JIA-associated uveitis.

  14. play
    03-05-2018 | Juvenile idiopathic arthritis | Conference coverage | Video

    Managing JIA-associated uveitis: The SHARE recommendations

    In this video, Athimalaipet Ramanan gives an overview of the key points from the SHARE initiative consensus recommendations on the screening, diagnosis, and management of juvenile idiopathic arthritis-associated uveitis.

  15. 10-04-2018 | Juvenile idiopathic arthritis | News | Article

    Recommendations for managing JIA-associated uveitis published

    The SHARE initiative has developed consensus evidence-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis.

  16. 20-06-2018 | Juvenile idiopathic arthritis | News | Article

    No increase in JIA-associated uveitis risk with etanercept treatment

    Patients with juvenile idiopathic arthritis who are treated with etanercept do not have a higher risk for developing uveitis than those given methotrexate, results of a UK cohort study suggest.

  17. 22-05-2018 | Juvenile idiopathic arthritis | News | Article
    News in brief

    ESR, disease activity associated with uveitis onset in JIA patients

    Study results suggest that laboratory biomarkers and disease activity scores could help to identify patients with juvenile idiopathic arthritis who have a high risk for uveitis.

  18. 03-01-2018 | Juvenile idiopathic arthritis | News | Article

    Adalimumab a potential treatment option for JIA-associated uveitis

    Adalimumab may be beneficial for patients with chronic anterior uveitis related to juvenile idiopathic arthritis and an inadequate response to topical therapy and methotrexate, results of the ADJUVITE trial suggest.

  19. 22-10-2019 | Teaser
    ACR/ARP 2019 clinical trial recommendation

    Reduction of Anterior Uveitis Flares in Patients with Axial Spondyloarthritis Following 1 Year of Treatment with Certolizumab Pegol: 48-Week Interim Results from a 96-Week Open-Label Study

    Sunday,   November 10, 17:00–17:15. Georgia World Congress Center, Atlanta, USA Presenting author:  Irene van der Horst-Bruinsma, Netherlands TRIAL RESULTS PUBLISHED  | Read the full story What our Advisory Board said: This is an important analysis for those treating resistant uveitis where certolizumab may have shown efficacy. – Laura Coates, UK

  20. 01-09-2017 | Juvenile idiopathic arthritis | News | Article

    Predictors of uveitis in children with JIA identified

    A Nordic cohort study has identified factors associated with the development of uveitis among children with juvenile idiopathic arthritis. Read the linked commentary from Sangeeta Sule

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.